share_log

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

Truist Securities Downgrades Axonics to Hold, Lowers Price Target to $71

Truist Securities将Axonics的评级下调至持有,将目标股价下调至71美元
Benzinga ·  01/12 15:29

Truist Securities analyst David Rescott downgrades Axonics (NASDAQ:AXNX) from Buy to Hold and lowers the price target from $73 to $71.

Truist Securities分析师戴维·雷斯科特将Axonics(纳斯达克股票代码:AXNX)的评级从买入下调至持有,并将目标股价从73美元下调至71美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发